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Abstract
Aim: This single blind cross-sectional study compared the vascular health of subjects suffering from severe chronic
periodontitis, severe aggressive periodontitis and periodontal healthy controls by evaluating pulse wave velocity (PWV),
augmentation index (AIx) and pulse pressure amplification (PPA).
Material and Methods: In a total of 158 subjects, 92 suffering from severe periodontitis and 66 matched periodontal
healthy controls, PWV, AIx, central and peripheral blood pressure were recorded using an oscillometric device
(Arteriograph).
Results: Subjects suffering from severe chronic or aggressive periodontitis exhibited significantly higher PWV (p= 0.00004),
higher AIx (p = 0.0049) and lower PPA (p = 0.028) than matched periodontal healthy controls.
Conclusions: The results of this study confirm the association between periodontal inflammation and increased
cardiovascular risk shown by impaired vascular health in case of severe periodontitis. As impaired vascular health is a
common finding in patients suffering from severe periodontal disease a concomitant routine cardiovascular evaluation may
be advised.
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Introduction
The association between oral inflammation and the risk for
myocardial infarction or stroke has been firstly described already
more than two decades ago [1,2]. Ever since, a steadily increasing
number of studies and reviews have firmly established a positive
association between atherosclerosis and periodontal inflammation
[3–5]. Preliminary intervention studies were able to prove the
positive influence of various periodontal therapeutic measures on
endothelial dysfunction, e.g. sub- and supragingival debridement
[6,7], debridement supplemented by systemic antibiotics [8] or
debridement in conjunction with local antibiotics [9]. For the
evaluation of endothelial dysfunction, the first measurable stage of
developing atherosclerosis, in these studies usually the flow-
mediated dilatation FMD (endothelium-dependent) or the nitro-
glycerin-mediated dilatation (endothelium-independent) of the
brachial artery, have been recorded. While the validity of data
obtained by FMD and nitro-glycerine-mediated dilatation has
been verified by various trials, both methods require a very high
level of examiner training to avoid faulty measurements and are
time-consuming and expensive. Therefore the need for less
expensive and clinically less demanding alternatives for routine
vascular recording lead to the re-evaluation of the well-established
principle of pulse wave velocity (PWV), augmentation index (AIx)
and central pressures as clinically highly relevant indicators of
vascular health.
The measurement of arterial stiffness by pulse wave reflection
may be regarded as a prognostic significant extension of
conventional vascular diagnosis. PWV is a direct marker of
arterial stiffness [10,11]. Increased PWV is a strong predictor for
future cardiovascular events and mortality in patients with and
without diverse risk factors, as for example end-stage renal disease
[12], patients with type 2 diabetes [13] hypertension [14], elderly
people [15] or the general population [16–18].
An indirect measure of arterial stiffness and a direct measure of
pulse wave reflection is the augmentation pressure and the
augmentation index [19]. Augmentation can be described as the
effect of wave reflection on the aortic systolic pressure peak.
Accordingly, augmentation is a measure for the additional
pressure caused by pulse wave reflection stressing the left ventricle
[20]. AIx may be calculated by dividing the augmentation pressure
by the pulse pressure. In principle, the AIx may be obtained by
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calculating the quotient of the pressure peak of the initial and the
reflected wave (Fig. 1 [19]. All parameters influencing the AIx
subsequently also have an impact on the central blood pressure.
The measurement of the pulse wave reflection therefore allows an
estimation of the central blood pressure, and may differ
substantially from the recordable peripheral blood pressure [19].
It correlates well with left ventricular mass in hypertensive and in
normotensive young men [21] and is an independent marker for
premature coronary artery disease [22]. In different populations
e.g. patients with end-stage renal failure, the AIx is also an
independent predictor of mortality [23].
Both, PWV and AIx, provide essential information on the status
of the arterial vascular system. The prognostic significance of
arterial stiffness is very high. Measurements of PWV and AIx
calculations allow stratifying patients with a high risk profile for
cardiac and cerebral events who might benefit from more intensive
cardiovascular treatment schemes [19].
Recently a new recording system for the assessment of vascular
function on the basis of recorded pulse wave data has been
developed, the so called Arteriograph. The Arteriograph was the
very first validated device that allowed the measurement of PWV,
AIx and central pressures by analysis of the oscillometric pressure
curves registered on the upper arm with a single pressure cuff [24].
The principle of the oscillometric method is based on plethys-
mography and registers oscillometric pulsatile pressure changes in
the brachial artery. Pressure fluctuations in the brachial artery are
revealed by a pressure sensor in the cuff passing the recorded data
to a computer for further analysis and computation of pulse
pressure waves (Fig. 1). PWV is calculated in m/s for a given
patient by relating the recorded time difference (ms) between the
onset of the first pulse wave and the onset of the reflected pulse
wave to the measured distance between the jugulum and the
symphysis. The AIx corresponds to the pressure difference
(amplitude difference; P1–P2, Fig. 1) between the first and second
wave in relation to the pulse pressure (PP). The Arteriograph
calculates the AIx based on a fixed formula and thus provides the
aortic AIx without applying a transfer function [24].
Aim
The aim of this cross sectional study was to assess the
cardiovascular status of patients suffering from severe aggressive
or chronic periodontitis by recording pulse wave velocity, aug-
men-tation index and central blood pressure with the Arteriograph
and compare it to data recorded from matched periodontal
healthy controls.
Materials and Methods
Study design
This investigation was designed as a single blind cross-sectional
trial. The study protocol, prepared in accordance with the
declaration of Helsinki of 1973 and meeting the GCP criteria,
was approved by the ethics committee of the University of
Wuerzburg. All subjects included have signed the informed
consent. A positive vote of the ethics committee of the University
of Wuerzburg from 2009 (file #39-09) is easily available (e.g. on
request via mail to the corresponding author).
Study setting
Study subjects were screened and recruited from individuals
seeking dental care at the School of Dental Medicine of the
University of Wuerzburg.
Inclusion criteria
Patients suffering from untreated severe generalised chronic or
aggressive periodontitis were eligible for participation in test
group. The diagnosis of generalised severe chronic or aggressive
periodontitis was based on the classification criteria of the
International Workshop for a Classification of Periodontal
Diseases and Conditions [25].
The severity of disease expression was categorized according to
the proposal of the working group of the Centers for Disease
Control (CDC) and the American Academy of Periodontology
(AAP) [26].
In order to restrict inclusion only to subjects with extensive
periodontal lesions study patients additionally had to meet the
following criteria: Patients with clinical detectable attachment loss
$6 mm in a minimum of two different sextants and a minimum of
Figure 1. Original recording of an oscillometrically generated pulse wave (modified by Baulmann et al. 2008).
doi:10.1371/journalone.0103449.g001
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six interproximal sites on six different teeth were eligible for
inclusion in the test group.
Individuals exhibiting minor periodontal pockets #3 mm were
designated periodontal healthy and were eligible for inclusion in
the control group.
Exclusion criteria
Individuals meeting the following criteria were not eligible for
study participation: Less than ten natural teeth, age ,18 years,
pregnancy or breastfeeding, infectious disease, systematic peri-
odontal therapy within the last five years, antibiotic medication
within the last six months, intellectual inability to fully compre-
hend the aims of the study, severely decayed teeth, atrial
fibrillation, or severe cardiac valve vitium.
Screening, recruitment and examination
A total of 724 subjects were screened, 256 met the inclusion
criteria. Ultimately 158 subjects (75 male/83 female) were enrolled
in the study. 92 patients were assigned to the test group (severe
periodontitis). 74 received the diagnosis of severe chronic
periodontitis and 18 suffered from aggressive periodontitis. 66
subjects served as periodontally healthy controls. Individuals
meeting the inclusion criteria after the screening examination
were informed about the aims of the study and asked for their
participation. All patients who participated in the study signed
informed consent and received an assessment of their periodontal
health by recording a comprehensive periodontal status as well as
an assessment of their cardiovascular status by using the
Arteriograph within the next seven days. For matching purposes
furthermore age, gender, weight, height, smoking habits and the
presence of known systemic medical problems (e.g. diabetes) were
recorded using a questionnaire.
Background factors
After setting the age of the evaluated subjects to older than 35
years it was not necessary to match the patients in the sense of pair
wise assignment. The limit of 35 years was chosen because in the
periodontitis group no one was younger than 36. After this
exclusion, except the peripheral pulse pressure, there were no
significant differences between the periodontally healthy controls
and the test group suffering from severe periodontal diseases
regarding the following parameters: gender, age, body mass index,
height, weight, smoking habits, arterial hypertension, and presence
of hypercholesterolemia. The same holds true for medication
(tables 1 and 2).
Periodontal examination
The periodontal examination comprised the following param-
eters: Number of intraoral visible teeth, pocket probing depth
(PPD) and clinical attachment level (CAL). Measurements were
performed at six sites per tooth using a CP-12 Marquis periodontal
probe (Hu Friedy Co., USA); Recorded measurements were
rounded to the nearest millimeter. All periodontal examinations
were executed by a single clinically experienced dentist. To ensure
the reproducibility of the clinical test results, an intra-individual
calibration was performed. For this, 4 phantom models with
periodontal defects with each 27 teeth were measured at two
points in time. The examiner was calibrated if the first
measurement and the measurement 48 hours later was were
equal at 75% of the measurements with total agreement and 95%
within61 mm [27].
Vascular examination
After the periodontal examination the recording of the
cardiovascular parameters was performed during a subsequent
appointment within the next seven days using the Arteriograph
(TensioMed Ltd, Hungary) with the corresponding TensioMed
analysis software (version 1.9.9.12).
In accordance with the international guidelines for the
implementation of arterial stiffness measurements, all measure-
ments were made in the same room under quiet conditions and
dim illumination, unaffected by external environmental influences
[28].
Firstly the distance between the sternal notch (jugulum) and the
symphysis was recorded with a tape measure. Subsequently, in
order to minimize sources of recording error each patient had a
rest period of ten minutes before the onset of the cardiovascular
measurements. All measurements were performed three times,
with a predetermined free interval of two minutes between the
individual measuring periods. During the examination the study
subjects lay relaxed on an examination couch with eyes closed. All
vascular data were recorded by the same trained medical technical
assistant who was unaware of the assignment of the study subjects
to the test or control group.
The analysis of the Arteriograph data was performed by an
experienced cardiologist (JB) who also was unaware of the
assignment of the data to the different groups.
Table 1. Clinical characteristics of the studied population.
Group
Unit no/mild periodontitis severe chronic/aggressive periodontitis P
n=66 n=92
Age years 55613 55610 0.71
BMI kg/m2 2564 2663 0.60
Male gender % 43,9 50,0 0.45
Smoker % 30,3 21,7 0.22
Hypertension % 17.2 22.5 0.44
Hypercholesteremia % 10.0 10.9 1.0
Values are expressed as mean 6 SD as a result of Mann-Whitney U-Test for age and BMI or in % as a result of Chi-squared for the others.
doi:10.1371/journalone.0103449.t001
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Statistical analysis
Statistical data analysis was performed by a professional
statistician using the WinMEDAS (C. Grund, Germany) statistical
software package.
To calculate the differences between both groups the Mann-
Whitney U-test was used for continuous variables. The Chi-
square-test or Fishers test for expected values below 5 was used for
nominal scale data. The level of significance was set to p,0.05.
Results
1. Pulse Wave Velocity (PWV)
The results of the PWV data analysis are depicted in figure 2.
Data evaluation revealed significantly higher PWV values for
patients suffering from severe chronic periodontitis or severe
aggressive periodontitis when compared to the periodontal healthy
controls (p = 0.00004).
2. Aortic Augmentation Index (AIx)
The results of the calculation of the AIx data for the test and
control group are shown in figure 3. AIx scores calculated for the
periodontally healthy individuals of the control group proved to be
significantly lower (p = 0.0049) than the AIx scores calculated for
those with severe aggressive periodontitis or severe chronic
periodontitis.
3. Pulse pressure amplification (PPA) and central pressure
In the periodontally healthy controls the peripheral diastolic
blood pressure was lower, peripheral systolic blood pressure higher
and consequently the peripheral pulse pressure significantly higher
(p = 0.0024) than the values recorded for the periodontitis group
(see table 3). However when central pulse pressures were
compared the differences disappeared, indicating that the pulse
pressure and thus the central pressure is higher and pulse pressure
amplification lower in the periodontitis group when compared to
the healthy controls (p = 0.028 for PPA, table 4). The observed
central augmentation pressure shows the tendency to be higher in
the periodontitis group (p= 0.064, table 4).
Discussion
The main finding of this study is that in patients suffering from
severe chronic or aggressive periodontitis arterial stiffness and
pulse wave reflection are significantly increased.
It further supports the evidence for an association between
periodontal and cardiovascular health and is in line with the data
of several other studies [1,29–32].
The specific relationship between arterial stiffness and peri-
odontitis was documented only once before in a subgroup of
patients suffering from arterial hypertension [33]. The data of that
study failed to prove a difference in PWV. They revealed a
significantly higher left ventricular hypertrophy and significant
differences in pulse wave reflection including increased central
aortic pressures and increased augmentation in the periodontal
disease group in the situation of arterial hypertension. A
correlation between the pulse wave velocity and oral inflammation
was, by contrast to our data, not confirmed. In terms of pulse wave
reflection the results are in concordance with the findings of this
study. We were able to identify higher AIx scores in the study
subjects suffering from severe periodontal disease when compared
to the periodontally healthy controls. Besides a higher sample rate
in our study the main difference between Franek’s and our study is
patient selection. As in many other studies the study by Franek et
al. 2009 evaluated a highly selected population. Only patients with
hypertension were included in their trial. Other studies have
shown that hypertensive patients themselves display higher pulse
wave velocity scores than patients with normal blood pressure
[14,34]. That may be one reason for the diverging study results.
Differences induced by hypertension might have superimposed
changes caused by periodontal inflammation. Whereas Franek
focused on a subgroup of hypertension we included a wide range
of cardiovascular compromised as well as cardiovascular healthy
subjects. The higher number of evaluated individuals (n = 724) in
the present study allowed for a meaningful statistical analysis.
Nevertheless, data analysis revealed that the mean peripheral
blood pressure of both groups is within the normal range (#140
systolic, and #90 diastolic). On the basis of a routine peripheral
blood pressure control by the method of Riva-Rocci, the average
individual in the test group would have been classified as patient
with no risk factor for cardiovascular events. This illustrates the
potential benefits of the oscillometric pulse wave analysis (e.g.
Arteriograph) compared to ordinary blood pressure measurements
for the detection of early or preclinical signs of cardiovascular
dysfunction.
Another point to discuss is the diagnosis and thus the grouping
of the patients. The use of the established Community Periodontal
Index of Treatment Needs CPITN [35], for classifying the severity
of periodontal disease as done in many previous investigations
including the study by Franek et al. should be questioned critically.
The scoring system of the CPITN tends to overestimate the
Table 2. Medication of the studied population.
Group
Unit no/mild periodontitis severe chronic/aggressive periodontitis P
n=66 n=91
Diuretics (treated) % 0 3.3 0.29
Statins (treated) % 8.8 12.0 0.54
b-Blockers (treated) % 7.0 16.3 0.086
Calcium channel blockers (treated) % 3.5 3.3 1.0
NSAID (treated) % 17.5 14.1 0.58
ACE-inhibitors (treated) % 8.8 15.2 0.24
Values are expressed in % as result of Chi-squared test. NSAID= non-steroidal anti-inflammatory drugs; ACE = angiotensin converting enzyme.
doi:10.1371/journalone.0103449.t002
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severity of periodontal disease expression [1,36]. For this reason,
in all study participants we recorded a comprehensive periodontal
status and the severity of disease expression was classified following
the proposal of the working group of the Centers for Disease
Control (CDC) and the American Academy of Periodontology
(AAP) [26]. To ensure the inclusion of individuals with a
substantial inflammatory burden in the periodontitis group, only
subjects with a minimum of six teeth displaying pockets depth $
6 mm were recruited, which is also in contrast to the disease
severity of patients evaluated in other preceding investigations.
Particularly in young individuals with a diagnosis of aggressive
periodontitis the recorded pulse wave velocity values were
significantly higher than those found in the periodontally healthy
controls (data not shown). This is consistent with findings from
other studies documenting a much stronger association between
periodontal infections and vascular endpoints in younger patients
[37,38]. By which mechanisms the observed vascular changes are
correlated with the manifestation of severe periodontal disease
may not be answered by the present data.
‘‘Translating’’ the arterial stiffness measurements observed in
this study into a biological vascular age may serve as an illustration
for the importance of the present findings [39]. For this purpose,
the results of the present study are compared to standard values
obtained from measurements made in the healthy general
population. Patients with aggressive periodontitis or severe chronic
periodontitis, displaying an average pulse wave velocity of 9.1 m/s
their biological vascular age is about 20 years higher than that of
the healthy age-corrected group and therefore pre-aged to a huge
extent. Even more dramatic are is the interpretation of the results
in terms of mortality and the incidence of cardiovascular events.
An increase in pulse wave velocity of 1 m/s implies an estimated
14% increased risk for cardiovascular events, and a 15% increased
risk for overall mortality rate accordingly to mortality rates of
Vlachopoulos’ review [17].
For the prediction of cardiovascular events the central pressure
is more important than the peripheral [40]. Again, the present
study revealed that periodontitis patients exhibit significantly
higher central pressures (expressed as PPA) than periodontal
healthy controls reflecting the higher cardiovascular risk of the
periodontitis patients. Increased PWV as marker of stiffening of
the large arteries suggest that periodontitis patients suffer from a
broad range of subclinical vasculature dysfunction.
Figure 2. Pulse wave velocity (PWV) data recorded for the 2 experimental groups.
doi:10.1371/journalone.0103449.g002
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The most frequently cited reason for the intake of beta-blocker
is the diagnosis ‘‘hypertension’’. Beta-blockers per se (possible
exception nebivolol) affect arterial stiffness possibly indirectly by
lowering of peripheral blood pressure and/or the initially ejected
pressure wave without changing central hemodynamics. Though
beta-blockers are known to lower PWV the group with the more
frequent intake of b-blockers is showing higher PWV (the
periodontitis group). One might speculate that if the intake of
beta-blockers would be completely uniformly distributed, the
difference in PWV of the groups could even be more pronounced.
Figure 3. Aortic Augmentation Index (AIx) data calculated for the 2 experimental groups.
doi:10.1371/journalone.0103449.g003
Table 3. Hemodynamic characteristics of the studied population.
Group
Unit no/mild periodontitis severe chronic/aggressive periodontitis P
n=66 n=92
Heart rate bpm 69610 67610 0.089
Peripheral systolic blood pressure mmHg 134621 129616 0.18
Peripheral diastolic blood pressure mmHg 80611 82610 0.89
Peripheral pulse pressure mmHg 54614 47610 0.0024**
Values are expressed as mean 6 SD as a result of Mann-Whitney U-Test.
doi:10.1371/journalone.0103449.t003
Vascular Health and Periodontitis
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The same holds true for PPA. Nevertheless both, the intake of
beta-blockers and the diagnosis hypertension, are not significantly
different in both groups.
This cross-sectional study shows for the first time a pathophys-
iological and highly significant predictive risk marker of PWV in
addition to the above described pulse wave reflection to be higher
in patients suffering from severe periodontitis. Further intervention
studies using these markers of vascular dysfunction and vascular
structure as endpoints may be required to elucidate possible causal
relationships between periodontal and cardiovascular disease.
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